Israel Englander’s Maravai LifeSciences MRVI Stock Holding History

Israel Englander’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-60,000	Closed	-$520K	–	6300
2024 Q1	$520K	Sell	60,000 -160,300	-73%	-$1.08M	﹤0.01%	4782
2023 Q4	$1.44M	Buy	220,300 +100,300	+84%	+$648K	﹤0.01%	3861
2023 Q3	$1.2M	Buy	120,000 +25,000	+26%	+$275K	﹤0.01%	4040
2023 Q2	$1.18M	Buy	+95,000	New	+$1.28M	﹤0.01%	3919
2023 Q1	–	Sell	-30,000	Closed	-$429K	–	6670
2022 Q4	$429K	Sell	30,000 -63,800	-68%	-$1M	﹤0.01%	4849
2022 Q3	$2.4M	Buy	93,800 +13,800	+17%	+$346K	﹤0.01%	3587
2022 Q2	$2.27M	Buy	+80,000	New	+$2.53M	﹤0.01%	3566

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's MRVI Position: Q2 2026 in Review

Israel Englander increased its Maravai LifeSciences (MRVI) stake by 295% in Q2 2026, buying an estimated $21M and bringing the position to 6,508,220 shares worth $40.6M. The position accounts for 0.01% of the portfolio, ranked #1030.

Israel Englander first reported a position in MRVI in Q4 2020 and has held it in 23 quarters since. The position peaked at $45.9M in Q3 2022. 177 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Israel Englander held 6,508,220 shares of Maravai LifeSciences worth $40.6M as of Q2 2026.
Israel Englander bought 4,858,730 Maravai LifeSciences shares in Q2 2026, an estimated $21M.
Maravai LifeSciences made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1030 holding.
Israel Englander first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 23 quarters since.
Israel Englander's Maravai LifeSciences position peaked at $45.9M in Q3 2022.
177 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.